Methylenetetrahydrofolate Dehydrogenase (NAD+) [methylentetrahydrofolátdehydrogenasa (NAD+)]
- Terms
-
5,10-methylentetrahydrofolátreduktasa (NADH)
methylentetrahydrofolátdehydrogenáza (NAD+)
metylentetrahydrofolátdehydrogenáza (NAD+)
-
5,10-Methylenetetrahydrofolate-Reductase (NADH)
5,10-Methylenetetrahydrofolate:NAD Oxidoreductase
Methylenetetrahydrofolate Dehydrogenase (NAD)
NADH-Dependent 5,10-Methylenetetrahydrofolate Reductase
A NAD-dependent oxidoreductase that catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5,10-methenyl-tetrahdyrofolate. It has been found in a variety of microorganisms.
- Annotation
- do not confuse with METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP)
- DUI
- D045102 MeSH Browser
- CUI
- M0013633
- Previous indexing
- Methylenetetrahydrofolate Reductase (1989-2003); Oxidoreductases (1999-2003)
- History note
- 2004; use METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP) 1989-2003; for 5,10-METHYLENETETRAHYDROFOLATE-REDUCTASE (NADH) use METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD+) (NM) 1999-2003;
- Public note
- 2004; see METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1989-2003; 5,10-METHYLENETETRAHYDROFOLATE-REDUCTASE (NADH) was indexed under OXIDOREDUCTASES 1999-2003
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine